Stock Analysts

Sony’s The Interview: Top Grossing Online Movie Release

Even amid controversies and threats, Sony Corporation ’s ( SNE ) recent most movie ‘The Interview’ became the highest grossing online release of the year. It generated revenues to the tune of $15 million from online viewers and $3 million from its theatrical screenings on the opening weekend. The movie was released on Christmas Eve at only about 331 theaters and was available online through Google Inc.’s ( GOOG ) YouTube Movies and Google Play, Microsoft Corp.’s ( MSFT ) Xbox Video and a dedicated website. […]

Stock Analysts

Amazon to Convert Holiday Prime Trial Users to Paid Ones?

As per Consumer Intelligence Research Partners’ predictions (“CIRP”), e-commerce giant Amazon.com Inc. ( AMZN ) could convert 70% of the 10 million holiday Prime trial members to paying members. On the basis of its analysis of earlier Prime member conversion and retention rates, CIRP forecasts that 7 million out of the 10 million new trial members will subscribe for a one-year Amazon Prime membership. […]

Mergers & Acquisitions

Weatherford Completes Sale of Engineered Chemistry and Drilling Fluids Businesses and Monetizes Proserv Interest

Weatherford Completes Sale of Engineered Chemistry and Drilling Fluids Businesses and Monetizes Proserv Interest PR Newswire BAAR, Switzerland, Dec. 31, 2014 BAAR, Switzerland , Dec. 31, 2014 /PRNewswire/ — Weatherford International plc (NYSE: WFT) closed the previously announced sale of the Company’s engineered chemistry and Integrity drilling fluids businesses to an affiliate of The Lubrizol Corporation, a Berkshire Hathaway company, for a purchase price of $750 million , subject to a customary post-closing working capital adjustment […]

Stock Analysts

American States Water Company Upgraded to Strong Buy

On Dec 31, 2014, Zacks Investment Research upgraded American States Water Company ( AWR ) to a Zacks Rank #1 (Strong Buy) from a Zacks Rank #2 (Buy). Why the Upgrade? American States Water reported strong third-quarter 2014 performance with earnings of 54 cents per share beating the Zacks Consensus Estimates by 14.9% […]

Stock Analysts

NeuroDerm Skyrockets on Parkinson’s Disease Study Data

NeuroDerm Ltd. ’s ( NDRM ) shares almost tripled (up 193.5%) after the company announced encouraging top-line data from a phase IIa pharmacokinetic study on its levodopa/carbidopa (LD/CD) candidates, ND0612H and ND0612L. NeuroDerm is evaluating ND0612L and ND0612H as a continuous, subcutaneous dosage of liquid LD/CD for moderate and advanced Parkinson's disease patients, respectively. […]